2-216689490-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000599.4(IGFBP5):c.337+4949A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.824 in 152,236 control chromosomes in the GnomAD database, including 51,891 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.82 ( 51891 hom., cov: 34)
Consequence
IGFBP5
NM_000599.4 intron
NM_000599.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.537
Publications
11 publications found
Genes affected
IGFBP5 (HGNC:5474): (insulin like growth factor binding protein 5) Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.861 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IGFBP5 | ENST00000233813.5 | c.337+4949A>G | intron_variant | Intron 1 of 3 | 1 | NM_000599.4 | ENSP00000233813.4 | |||
| IGFBP5 | ENST00000449583.1 | c.337+4949A>G | intron_variant | Intron 1 of 1 | 3 | ENSP00000413474.1 | ||||
| IGFBP5 | ENST00000486341.1 | n.229+4949A>G | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes AF: 0.824 AC: 125360AN: 152118Hom.: 51871 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
125360
AN:
152118
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.824 AC: 125429AN: 152236Hom.: 51891 Cov.: 34 AF XY: 0.822 AC XY: 61135AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
125429
AN:
152236
Hom.:
Cov.:
34
AF XY:
AC XY:
61135
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
32540
AN:
41518
American (AMR)
AF:
AC:
11712
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
2878
AN:
3468
East Asian (EAS)
AF:
AC:
3925
AN:
5180
South Asian (SAS)
AF:
AC:
4064
AN:
4822
European-Finnish (FIN)
AF:
AC:
8723
AN:
10600
Middle Eastern (MID)
AF:
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
AC:
58973
AN:
68032
Other (OTH)
AF:
AC:
1697
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1130
2260
3391
4521
5651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2565
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.